Ignite Creation Date:
2024-05-06 @ 1:37 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01858259
Status:
UNKNOWN
Last Update Posted:
2014-08-13
First Post:
2013-05-14
Brief Title:
Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis
Sponsor:
Gabriela Riemekasten
Organization:
Charite University Berlin Germany
Study Overview
Official Title:
Prevention and Treatment of Interstitial Lung Disease in Systemic Sclerosis
Status:
UNKNOWN
Status Verified Date:
2014-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Systemic sclerosis SSc is an orphan multiorgan disease affecting the connective tissue of the skin and all internal organs Interstitial lung disease is a frequent morbidity and mortality-driving manifestation in systemic sclerosis
This observational trial OT is part of the collaborative project DeSScipher one out of five OTs to decipher the optimal management of systemic sclerosis Aim of this observational try is to identify
The state of clinical practice in Europe for prevention and treatment of interstitial lung disease and its impact on lung function and disease progression
The potential predictors and confounders for response to therapy
This observational trial OT is part of the collaborative project DeSScipher one out of five OTs to decipher the optimal management of systemic sclerosis Aim of this observational try is to identify
The state of clinical practice in Europe for prevention and treatment of interstitial lung disease and its impact on lung function and disease progression
The potential predictors and confounders for response to therapy
Detailed Description:
Patients are routinely evaluated every 3 months over a 12-months period by medical history physical examination pulmonary function tests VAS lung score and SF-36 SHAQ Also their medication and possible medication changes will be recorded
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None